-
Feil på unn.noDeler av innholdet på unn.no vises ikke. Det gjelder flere sider, men det jobbes med saken. Vi håper å få løst problemet i løpet av torsdag 11. september. Det er prioritert.
Tjenesten bidrar med rådgivning i forbindelse med diagnostikk og behandling av immunbetingede trombocytopenier, og kan skaffe forlikelige blodprodukter til pasienter med spesielle og kompliserte transfusjonsbehov. Analysering, utredning og rådgivning ved trombocytopenier som ikke skyldes antistoffer, inngår ikke i tjenestens aktivitet.
- Informasjonsbrosjyre - Nasjonal behandlingstjeneste for avansert trombocyttimmunologi (pdf)
- Rekvisisjon til trombocyttimmunologi
- Føtal neonatal alloimmun trombocytopeni (pasientinformasjon)
- FNAIT- Fetal/neonatal alloimmune thrombocytopenia (patient information – English)
Nyhetsarkiv
Nasjonal behandlingstjeneste for avansert trombocyttimmunologi mottok Helse Nords forskningpris 2022
Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology (Platelets 2022)
Human Papilloma Virus Vaccine and VITT antibody induction (Am J Hematol. 2022)
The SSC platelet immunology register of VITT and VIITP (JTH 2021)
Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody (ImmunoHorizons, 2022)
Når forskning haster (Bioingeniøren, 2021)
Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series (Frontiers in Neurology, 2021)
Covid-19 vaccination, adverse events, and detection of antibodies (Thrombosis Research, 2021)
Thrombocytopeniawith acute ischemic stroke and bleeding in a patient newly vaccinated with anadenoviral vector-based COVID-19 vaccine (Journal of Thrombosis and hemostasis, 2021)
Preclinical evaluation of immunotherapeutic regimens forfetal/neonatal alloimmune thrombocytopenia (Blood Advances, 2021)
Fighting anti-CD36–mediated FNAIT (Blood, 2021)
An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination (Journal of Thrombosis and hemostasis 2021)
Recommendations for the clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) for SARS-CoV-2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology (Journal of Thrombosis and hemostasis 2021)
Nyoppdaget katastrofal antistoffdannelse etter AstraZeneca-vaksinen (Tidsskriftet Den norske legeforeningen 4/2021)
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination (the New England Journal of Medicine, 2021)
Hit happens (Bioingeniøren 7/2019)